| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/04/2009 | EP2030986A1 Polypeptide derivative of parathyroid hormone (PTH) |
| 03/04/2009 | EP2030968A2 Sulfur-containing compound, method of preparation and pharmaceutical uses thereof |
| 03/04/2009 | EP2029728A2 Methods and compositions for repairing cartilage |
| 03/04/2009 | EP2029596A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same |
| 03/04/2009 | EP2029539A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 03/04/2009 | EP2029184A1 Injectable fibrin composition for bone augmentation |
| 03/04/2009 | EP2029145A2 Pyrrolopyrimidine compounds and their uses |
| 03/04/2009 | EP2029142A1 Composition for induction or inhibition of stem cell differentiation |
| 03/04/2009 | EP2029138A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| 03/04/2009 | EP1740198A4 Anti-aging effects of substance p |
| 03/04/2009 | EP1546150B1 Pyrrole derivatives as inhibitors of cyteine proteases |
| 03/04/2009 | EP1506951B1 Method for the preparation of total salvianolic acid |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1472209B1 Lipoxin a4 analogs |
| 03/04/2009 | EP1463758B1 Mammalian prolactin variants |
| 03/04/2009 | EP1452527B1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
| 03/04/2009 | EP1401863B1 Somatostatin-dopamine chimeric analogs |
| 03/04/2009 | EP1379135B1 Formulations comprising entrapped active ingredients and uses thereof |
| 03/04/2009 | EP0869974B1 Compounds with growth hormone releasing properties |
| 03/04/2009 | CN201200626Y Tablet capsule containing diphosphonates tablet and vitamin D tablet |
| 03/04/2009 | CN101379053A New citrate salt of an indole derivative and its pharmaceutical use |
| 03/04/2009 | CN101379049A Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same |
| 03/04/2009 | CN101378754A Pharmaceutical use of 2-hydroxy-3- [5- (morpholin-4- ylmethyl) pyridine-2-yl] -1H- indole-5-carbonitrile as a free base or salts |
| 03/04/2009 | CN101375970A External-use liniment for arthralgia induced by hyperplasia of lumbar disc and cervical vertebra disc |
| 03/04/2009 | CN101375954A Medicament composition, preparation method thereof and use |
| 03/04/2009 | CN101375909A Moxa roll containing carbon powder of erberry |
| 03/04/2009 | CN101375868A Technique for extracting pine and cypress vigor element from branches and leaves, roots and barks, and flower bulbs of pine and cypress |
| 03/04/2009 | CN101375854A Medicinal preparation for treating osteoarthritis |
| 03/04/2009 | CN101375834A Solid dispersion of Ailamode and preparation method thereof and medicament application |
| 03/04/2009 | CN100465186C A composition and a method for inhibiting platelet aggregation |
| 03/04/2009 | CN100464780C A hot compress medicine for treating omitis and a preparation method thereof |
| 03/04/2009 | CN100464767C A medicine composition for treating hyperuricemia |
| 03/03/2009 | US7498416 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 03/03/2009 | US7498406 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/03/2009 | US7498358 Human ADAM-10 inhibitors |
| 03/03/2009 | US7498352 TGF-β superfamily production/secretion promoter |
| 03/03/2009 | US7498335 Method of producing an antiangiogenic or vascular permeability reducing effect |
| 03/03/2009 | US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors |
| 03/03/2009 | US7498323 Spiro-piperidine compounds and medicinal use thereof |
| 03/03/2009 | US7498301 Administering or applying anserine for treating muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, stress and myocardial infarction optionally with a diuretic |
| 03/03/2009 | US7498157 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators |
| 03/03/2009 | US7498143 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 03/03/2009 | US7498129 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification |
| 03/03/2009 | US7498032 Methods for treating immune disorders or cancer with anti-CD40 antibodies |
| 03/03/2009 | US7498031 Treating sensorineural hearing loss or a vestibular disorder by administering an a PM-1antibody or an MR16-1 antibody; Meniere's disease, drug-induced inner ear disorders, viral inner ear disorders, purulent inner ear disorders, temporal bone fracture or acoustic nerve tumor |
| 03/03/2009 | CA2442878C New process for the industrial synthesis of strontium ranelate and its hydrates |
| 03/03/2009 | CA2433714C Arthritis preventing or treating agent |
| 03/03/2009 | CA2420222C Orally administered peptides to ameliorate atherosclerosis |
| 03/03/2009 | CA2410880C 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 03/03/2009 | CA2351617C Method for inhibiting dental resorptive lesions |
| 02/26/2009 | WO2009026334A2 Treatment with kallikrein inhibitors |
| 02/26/2009 | WO2009026265A1 A method of extending the dose range of vitamin d compounds |
| 02/26/2009 | WO2009026158A2 Inflammation-regulating compositions and methods |
| 02/26/2009 | WO2009025300A1 Peptide capable of binding to immunoglobulin |
| 02/26/2009 | WO2009024670A2 Hyaluronic acid injectable gel for treating joint degeneration |
| 02/26/2009 | WO2009023918A1 Method of producing plant extract formulations |
| 02/26/2009 | WO2008030579A3 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 02/26/2009 | US20090054511 S)-(+)-N-acetyl-2,4,6-tribromo-5-methoxytryptophan methyl ester (4) from (S)-(+)-N-acetyl-5-methoxytryptophan methyl ester; osteoporosis, osteoblast activator |
| 02/26/2009 | US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis |
| 02/26/2009 | US20090054467 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases |
| 02/26/2009 | US20090054451 Use of Piperidine Derivatives as Agonists of Chemokine Receptor Activity |
| 02/26/2009 | US20090054424 Optically active pyridine derivative and a medicament containing the same |
| 02/26/2009 | US20090054409 [4-(4-imidazo[1,2-a]pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-morpholin-4-yl-methanone, used for treating rheumatoid arthritis in mammals |
| 02/26/2009 | US20090054392 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | US20090054386 Compositions and Methods for Inducing Bone Growth and Inhibiting Bone Loss |
| 02/26/2009 | US20090054356 1-substituted-7-(b-d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 02/26/2009 | US20090054336 Binding Agent |
| 02/26/2009 | US20090054323 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT |
| 02/26/2009 | US20090053763 Tumor endothelial marker 7-alpha molecules and uses thereof |
| 02/26/2009 | US20090053324 Calcium supplements |
| 02/26/2009 | US20090053234 Methods of Preventing or Treating Inflammatory or Autoimmune Disorders by Administering Integrin ALPHAVBETA3 Antogonists in Combination with other Prophylactic or Therapeutic Agents |
| 02/26/2009 | US20090053231 Optical Disc Apparatus |
| 02/26/2009 | US20090053192 Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof |
| 02/26/2009 | US20090053189 Molecules involved in regulation of osteoblast activity and osteoclast activity, and methods of use thereof |
| 02/26/2009 | DE202008000655U1 Zusammensetzung zur Behandlung von Beschwerden und Erkrankungen der Muskeln und der Gelenke Composition for the treatment of disorders and diseases of the muscles and joints |
| 02/26/2009 | CA2734577A1 Inflammation-regulating compositions and methods |
| 02/26/2009 | CA2697079A1 A method of extending the dose range of vitamin d compounds |
| 02/26/2009 | CA2697020A1 Method of producing plant extract formulations |
| 02/26/2009 | CA2696208A1 Treatment with kallikrein inhibitors |
| 02/26/2009 | CA2691600A1 Hyaluronic acid injectable gel for treating joint degeneration |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP2027872A1 Neurotoxic component of a botulinum toxin for treating a facial disease |
| 02/25/2009 | EP2027855A1 Use of gestagens in combination with (6S)5-methyl tetrahydro folate for endometriosis therapy with simultaneous reduction of the side effects of therapy and reduction in the risk of congenital deformities for with the onset of pregnancy |
| 02/25/2009 | EP2027124A1 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| 02/25/2009 | EP2026842A1 N-terminal modified peg-trail, method for preparing and uses thereof |
| 02/25/2009 | EP2026821A1 Hyaluronic acid binary mixtures and therapeutic use thereof |
| 02/25/2009 | EP2026806A2 Use of vx-702 for treating rheumatoid arthritis |
| 02/25/2009 | EP2026794A1 Xanthone derivative for the treatment of muscular disorders |
| 02/25/2009 | EP2026788A1 Therapeutic combination for painful medical conditions |
| 02/25/2009 | EP1254106B1 Calcilytic compounds |
| 02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
| 02/25/2009 | EP0852587B1 Synthetic peptides that inhibit il-6 activity |
| 02/25/2009 | CN101374838A 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin k and s inhibitors |
| 02/25/2009 | CN101374529A Method of stabilizing s-adenosyl-l-methionine and stabilized composition |
| 02/25/2009 | CN101371878A External-use Chinese medicinal composition for treating painful swelling disease |
| 02/25/2009 | CN101371842A Lornoxicam microsphere and preparation method thereof |
| 02/25/2009 | CN101371823A Technique for preparing double-acetyl emodic acid sustained-release capsules |
| 02/25/2009 | CN101371710A Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof |
| 02/24/2009 | US7495081 Framework patched anti-CD20 antibody |
| 02/24/2009 | US7495018 An enzyme inhibitor of p38 MAP kinase, an antagonist of tumor necrosis factors or adenosine receptor, a thiazole with the 5-pyridyl group derivatives |